H.C. Wainwright raised the firm’s price target on Vericel (VCEL) to $64 from $60 and keeps a Buy rating on the shares following the Q4 report. The company’s 2026 revenue outlook is conservative given that Vericel noted Q1 sales growth is already trending towards 20%, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VCEL:
- Vericel reports Q4 EPS 45c, consensus 38c
- Vericel sees FY26 revenue $316M-$326M, consensus $325.31M
- VCEL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Vericel: Strong MACI-Driven Performance, Robust Balance Sheet, and Multi-Pronged Growth Catalysts Support Buy Rating and $60 Target
- Vericel: Underappreciated High-Growth MACI Leader with Strengthening Profitability and a Long Runway Justifying Buy Rating